You are here

inotuzumab

Pfizer halts study of lymphoma drug unlikely to help survival

Reuters

Tue, 05/21/13 - 10:08 am

non-Hodgkin's lymphoma

Micromet Unveils Another Fast Route To Market, Marks Pfizer As Lead Competitor

Seeking Alpha

Sun, 10/16/11 - 07:05 pm

acute lymphoblastic leukemia

Seattle Genetics